Fraserna Life Sciences Canada Ltd.
We are a CRDMO company founded in 2020 focusing on viral vector and nucleic acid drugs. We have the most advanced technology empowered by strong R&D capability and large-scale commercial production facilities in China and North America. The Shanghai facility is over 70000 m2 and has been opened to customers while the remaining is under accelerated construction.
Our one-stop service platform of viral vector and nucleic acid drugs to help customers from drug discovery, proof-of-concept study, preclinical study, to CMC development, commercialization, and regulatory filing including IND and BLA.